Item 5.03.
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
Reverse
Stock Split
As
discussed in greater detail under Item 5.07, below, on December 15, 2022, at a Special Meeting of the Stockholders (the “Special
Meeting”), of 180 Life Sciences Corp. (the “Company,” “we,” “our,”
or “us”), the stockholders of the Company approved an amendment to the Company’s Second Amended and Restated
Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding shares of our common stock, par
value $0.0001 per share, by a ratio of between one-for-four to one-for-twenty, inclusive, with the exact ratio to be set at a whole number
to be determined by our Board of Directors or a duly authorized committee thereof in its discretion, at any time after approval of the
amendment and prior to December 15, 2023 (the “Stockholder Authority”).
On
December 15, 2022, and following the Special Meeting, the Company’s Board of Directors (the “Board”), with the
Stockholder Authority, approved an amendment to our Second Amended and Restated Certificate of Incorporation to effect a reverse stock
split of our common stock at a ratio of 1-for-20 (the “Reverse Stock Split”). The Reverse Stock Split is more fully
described in the Company’s definitive proxy statement, which was filed with the Securities and Exchange Commission (the “Commission”)
on November 16, 2022.
Immediately
after the Special Meeting and the approval thereof by the Board, on December 15, 2022, we filed a Certificate of Amendment to our Second
Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the
State of Delaware to effect the Reverse Stock Split. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and
is incorporated by reference herein.
Pursuant
to the Certificate of Amendment, the Reverse Stock Split will be effective on December 19, 2022 at 12:01 a.m. Eastern Time (the “Effective
Time”). The shares of the Company’s common stock are expected to begin trading on the NASDAQ Capital Market (“NASDAQ”)
on a post-split basis on December 19, 2022, with new CUSIP number: 68236V203. No change was made to the trading symbol for the Company’s
shares of common stock or public warrants, “ATNF” and “ATNFW”, respectively, in connection with the Reverse Stock
Split.
At
the Effective Time, every twenty (20) shares of issued and outstanding common stock will be converted into one (1) share of issued and
outstanding common stock, and the total outstanding shares of common stock will be reduced from approximately 40.5 million to approximately
2.0 million, without giving effect to any rounding up of fractional shares. The Company’s transfer agent, Continental Stock Transfer
& Trust Company (“Continental”), will serve as exchange agent for the Reverse Stock Split and will provide instructions
to stockholders of record regarding the Reverse Stock Split, to the extent applicable.
Because
the Certificate of Amendment did not reduce the number of authorized shares of our common stock, the effect of the Reverse Stock Split
was to increase the number of shares of our common stock available for issuance relative to the number of shares issued and outstanding.
The Reverse Stock Split did not alter the par value of our common stock or modify any voting rights or other terms of our common stock.
No
fractional shares will be issued in connection with the Reverse Stock Split. Stockholders of record who otherwise would be entitled to
receive fractional shares, will be entitled to have their fractional shares rounded up to the nearest whole share. No stockholders will
receive cash in lieu of fractional shares.
Each
certificate that immediately prior to the Effective Time represented shares of our common stock (“Old Certificates”)
shall thereafter represent that number of shares of our common stock into which the shares of our common stock represented by the Old
Certificate shall have been combined, subject to the adjustment for fractional shares as described above. Unless otherwise requested
by the stockholder, Continental will be issuing all of the post-split shares in paperless, “book-entry” form, and
unless otherwise requested by the stockholder, Continental will hold the shares in an account set up for the stockholder. All book-entry
or other electronic positions representing issued and outstanding shares of our common stock will be automatically adjusted. Those stockholders
holding our common stock in “street name” will receive instructions from their brokers.
In
addition, the number of shares of common stock issuable upon exercise of our stock options and other equity awards (including shares
reserved for issuance under the Company’s equity compensation plans) were proportionately adjusted by the applicable administrator,
using the 1-for-20 ratio, and rounded down to the nearest whole share, to be effective at the Effective Time, pursuant to the terms of
the Company’s equity plans. The conversion rates of our preferred stock will also be adjusted in a ratio of 1-for-20. The number
of shares issuable upon exercise of our outstanding warrants to purchase shares of common stock outstanding at the Effective Time will
also be equitably adjusted pursuant to the terms of such securities in connection with the 1-for-20 Reverse Stock Split. In addition,
the exercise price for each outstanding stock option and warrant will be increased in inverse proportion to the 1-for-20 split ratio
such that upon an exercise, the aggregate exercise price payable by the optionee or warrant holder to the Company for the shares subject
to the option or warrant will remain approximately the same as the aggregate exercise price prior to the Reverse Stock Split, subject
to the terms of such securities.
Further,
pursuant to the terms of the Company’s Class K Special Voting Shares (the “Preferred Stock”), following the
Effective Time, the Preferred Stock is now convertible into a number of shares of common stock equal to, and votes a number of voting
shares equal to, 264 shares.
Each
stockholder’s percentage ownership interest in the Company and proportional voting power remains virtually unchanged as a result
of the Reverse Stock Split, except for minor changes and adjustments that will result from rounding fractional shares into whole shares.
The rights and privileges of the holders of shares of common stock will be substantially unaffected by the Reverse Stock Split.
The
above description of the Certificate of Amendment and the Reverse Stock Split is a summary of the material terms thereof and is qualified
in its entirety by reference to the Certificate of Amendment, a copy of which is attached hereto as Exhibit 3.1 and is incorporated
herein by reference.
Reason
for the Reverse Stock Split
The Company is effecting the Reverse
Stock Split to satisfy the $1.00 minimum bid price requirement, as set forth in Nasdaq Listing Rule 5550(a)(2), for continued listing
on The NASDAQ Capital Market. As previously disclosed in a Current Report on Form 8-K filed with the Securities and Exchange Commission
on October 4, 2022, on September 30, 2022, the Company received a deficiency letter from the Listing Qualifications Department (the “Staff”)
of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days, the
closing bid price for the common stock was trading below the minimum $1.00 per share requirement for continued inclusion on The Nasdaq
Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). In accordance with Nasdaq
Rules, the Company has been provided an initial period of 180 calendar days, or until March 29, 2023 (the “Compliance Date”),
to regain compliance with the Bid Price Requirement. If at any time before the Compliance Date the closing bid price for the Company’s
common stock is at least $1.00 for a minimum of 10 consecutive business days, the Staff will provide the Company written confirmation
of compliance with the Bid Price Requirement. By effecting the Reverse Stock Split, the Company expects that the closing bid price for
the common stock will increase above the $1.00 per share requirement.
Item 5.07.
Submission of Matters to a Vote of Security Holders.
The
information provided in Item 5.03 is hereby incorporated into this Item 5.07 by reference.
On
December 15, 2022, the Company held the above referenced Special Meeting. Stockholders representing 26,233,176.27 shares of the Company’s
capital stock entitled to vote at the Special Meeting were present in person or by proxy representing 64.8% of the voting shares issued
and outstanding on the record date of November 7, 2022 and constituting a quorum to conduct business at the Special Meeting. The following
sets forth the matters that were voted upon by the Company’s stockholders at the Special Meeting and the voting results for such
matters. These matters are described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the
Securities and Exchange Commission (the “Commission”) on November 16, 2022 (the “Proxy Statement”).
At
the Special Meeting, stockholders approved the following proposals, which are set forth in their entirety below.
| 1. | Proposal
No. 1: Approval of an amendment to our Second Amended and Restated Certificate of Incorporation, as amended, to effect a reverse
stock split of our issued and outstanding shares of our common stock, par value $0.0001 per share, by a ratio of between one-for-four
to one-for-twenty, inclusive, with the exact ratio to be set at a whole number to be determined by our Board of Directors or a duly authorized
committee thereof in its discretion, at any time after approval of the amendment and prior to December 15, 2023: |
For |
|
|
Against |
|
|
Abstentions |
|
|
Broker
Non-Votes |
|
|
23,591,815.27 |
|
|
|
2,588,618 |
|
|
|
52,743 |
|
|
|
0 |
|
Proposal
No. 1 was approved by approximately 58.3% of the aggregate total of the Company’s outstanding voting shares as of the record date,
and as such Proposal No. 1 was approved by a majority of the issued and outstanding shares of our voting stock entitled to vote at the
Special Meeting.
|
2. |
Proposal
No. 2: Approval of the adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not
sufficient votes at the time of the Special Meeting to approve the above proposal: |
For |
|
|
Against |
|
|
Abstentions |
|
|
Broker
Non-Votes |
|
|
23,047,400.27 |
|
|
|
2,542,361 |
|
|
|
643,415 |
|
|
|
0 |
|
While
Proposal No. 2 was approved, because Proposal No. 1 was also approved, the approval of Proposal No. 2 had no effect.